ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse ModelsLinxi Zhu, Rodney J. Y. Ho, James I. Griffin et al.|Pharmaceutics|2021Cited by 18
Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasisQingxin Mu, Rodney J. Y. Ho, Jesse Yu et al.|PLoS ONE|2020Cited by 13
Novel Long-Acting Drug Combination Nanoparticles Composed of Gemcitabine and Paclitaxel Enhance Localization of Both Drugs in Metastatic Breast Cancer NodulesJesse Yu, Rodney J. Y. Ho, Qingxin Mu et al.|Pharmaceutical Research|2020Cited by 8